The serotonin receptor antagonist sarpogrelate improves coronary microcirculation

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1327, 2002-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antinociception in rat by sarpogrelate, a selective 5-HT 2A receptor antagonist, is peripheral

By Obata H.   Saito S.   Ishizaki K.   Goto F.  

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

The 5-Hydroxytryptamine2A Receptor Antagonist Sarpogrelate Hydrochloride Inhibits Acute Platelet Aggregation in Injured Endothelium

By Houkin K   Nakayama N   Nonaka T   Koyanagi I  

The Journal of International Medical Research, Vol. 34, Iss. 1, 2006-01 ,pp. : 65-72

Field House Publishing

Access to resources Recommend Favorite

Effects of the 5-HT Receptor Antagonist Sarpogrelate in Diabetic Patients with Complications : A Pilot Study

By Hotta N.  

Clinical Drug Investigation, Vol. 18, Iss. 3, 1999-09 ,pp. : 199-207

Adis International

Access to resources Recommend Favorite

EMD 281014, a new selective serotonin 5-HT 2A receptor antagonist

By Bartoszyk G.D.   van Amsterdam C.   Bottcher H.   Seyfried C.A.  

European Journal of Pharmacology, Vol. 473, Iss. 2, 2003-07 ,pp. : 229-230

Elsevier

Access to resources Recommend Favorite

The GABA B receptor antagonist CGP36742 improves learned helplessness in rats

By Nakagawa Y.   Sasaki A.   Takashima T.  

European Journal of Pharmacology, Vol. 381, Iss. 1, 1999-09 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite